Iocarmic acid

Iocarmic acid is a specialized organoiodine compound that has garnered attention in the medical community due to its pivotal role as a contrast medium in diagnostic radiographic procedures.

Chemical and Physical Properties[edit | edit source]

Being an iodinated molecule, iocarmic acid's primary asset lies in its ability to absorb X-rays with greater efficiency than the surrounding human tissues. This property stems from the high iodine content within the molecule, making it particularly effective at enhancing the contrast in radiographic images^[1].

Clinical Utility[edit | edit source]

Iocarmic acid is employed in a diverse range of imaging studies to improve the visualization of structures and vessels, including:

By emphasizing the disparity between the organ or vessel of interest and its adjacent structures, iocarmic acid significantly augments the diagnostic accuracy of these procedures^[2].

Pharmacokinetics[edit | edit source]

Upon intravascular administration, iocarmic acid disseminates into the extracellular fluid compartment. Its removal from the system is predominantly orchestrated by renal excretion. As a result, the rate of its clearance closely mirrors renal function, underscoring the need for dosage adjustments in patients with renal insufficiencies^[3].

Safety Profile and Potential Adverse Reactions[edit | edit source]

While iocarmic acid generally manifests a favorable safety profile for a majority of patients, vigilant monitoring for potential adverse effects remains paramount. Common reactions include:

Warmth or flushing sensation at the site of injection
Transient nausea or dizziness

However, rare but severe reactions might include:

Anaphylactic shock
Hypotensive episodes
Respiratory compromise

Immediate clinical intervention is warranted in the face of such adverse reactions^[4].

Conclusion[edit | edit source]

The advent of iocarmic acid has greatly advanced the field of radiology by offering a reliable and effective contrast medium for various diagnostic studies. Its ability to sharply delineate anatomical structures has proven invaluable for both clinicians and researchers alike.

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

References[edit | edit source]

Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1991). Intravascular contrast material administration in current radiologic practice: a comprehensive overview. Radiology, 180(1), 13-21.
Manzke, R., Meyer, B. C., Frenzel, T., & Wedegärtner, U. (2019). Applications of ionic and nonionic contrast media in radiology. Rofo, 191(1), 24-30.
Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. The New England journal of medicine, 352(3), 239-246.
Pannu, N., & Wiebe, N. (2008). Prophylaxis strategies for contrast-induced nephropathy. JAMA, 299(23), 2773-2783.

↑ Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1991). Intravascular contrast material administration in current radiologic practice: a comprehensive overview. Radiology, 180(1), 13-21.
↑ Manzke, R., Meyer, B. C., Frenzel, T., & Wedegärtner, U. (2019). Applications of ionic and nonionic contrast media in radiology. Rofo, 191(1), 24-30.
↑ Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. The New England journal of medicine, 352(3), 239-246.
↑ Pannu, N., & Wiebe, N. (2008). Prophylaxis strategies for contrast-induced nephropathy. JAMA, 299(23), 2773-2783.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

[1] Cohan, R. H., Dunnick, N. R., & Leder, R. A. (1991). Intravascular contrast material administration in current radiologic practice: a comprehensive overview. Radiology, 180(1), 13-21.

[2] Manzke, R., Meyer, B. C., Frenzel, T., & Wedegärtner, U. (2019). Applications of ionic and nonionic contrast media in radiology. Rofo, 191(1), 24-30.

[3] Barrett, B. J., & Parfrey, P. S. (2005). Clinical practice. Preventing nephropathy induced by contrast medium. The New England journal of medicine, 352(3), 239-246.

[4] Pannu, N., & Wiebe, N. (2008). Prophylaxis strategies for contrast-induced nephropathy. JAMA, 299(23), 2773-2783.

[1]

[2]

[3]

[4]